series-a
Stage
1
Investors
About
Obalon develops a swallowable, gas-filled, FDA-approved intragastric balloon system designed to assist adults with a BMI of 30 to 40 kg/m2 in weight loss when combined with diet and exercise. The balloons must be removed within 6 months and are intended for patients without prior weight-loss surgeries.
Explore Obalon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.